Life Science Analytics Market Outlook (2022 to 2032)
[299 Pages Report] The global life science analytics market is projected to grow at US$ 24.8 Billion in 2022 and is projected to grow at a compound annual growth rate of 10.7%, reaching US$ 68.6 Billion by 2032 during the forecast period.
The adoption of Artificial Intelligence in Healthcare is set to dramatically reshape the Research and Development and business sectors in order to promote global market growth over the next few decades.
Attributes
Details
Life Science Analytics Market CAGR (2022 to 2032)
10.7%
Life Science Analytics Market Size (2022)
US$ 24.8 Billion
Life Science Analytics Market Size (2032)
US$ 68.6 Billion
As life science companies adopt advanced analytics methods, they face pressure to reduce medical costs, increase efficiency, and adopt analytics solutions in clinical trials and drug development.
EMR solutions that are integrated with other technology services such as eHealth and telemedicine enable healthcare providers to create a fully interconnected environment for diagnosing and prescribing medications using the combined capabilities of HCIT. Life science analytics is expected to grow due to COVID-19 outbreaks, the shortage of healthcare professionals, and improved data management.
Life sciences are undergoing rapid change accompanied by global competition. Scientific and medical advances promise a better future for individuals all over. As a result, industry leaders must stay abreast of the latest trends and issues that are coming up, such as increased competition, changing consumer behavior, regulation, and the appearance of new players.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
What is the potential of the Life Science Analytics market?
Pharmaceutical companies increasingly use digital transformation to improve their value chain processes to become more productive and profitable in the market. With the aid of modern-day technological advancements, such as ubiquitous computing, big data, analytics, and mobility technologies, organizations can make significant improvements to their Research and Development productivity, product development, sales growth, CRM, and governance.
Several manufacturers and Research and Development organizations are automating operations processes by integrating analytics technologies to automatically collect operational data in the market. Advances in technology that integrate AI and ML will further boost the global market for life science analytics.
Implementation of paperless technologies in various laboratories to further boost the market for life science analytics. As a result, this has been proven to decrease process times while reducing errors.
Increasing numbers of chronic diseases, efforts to curb healthcare costs, and the need for improving patient outcomes are among the factors driving the need for improved data standardization in this market. Moreover, increasing government investments in healthcare infrastructure will propel market development for life science analytics.
Business intelligence tools for the life sciences industry enable biopharma companies to maintain the security of their data and track results quickly and compare results across clinical trials with historic genomic information. The process of creating life-saving medicines is time-consuming and expensive. In order to make progress in the field of life sciences, many companies rely on Research and Development grants.
The life science industry is producing increasing amounts of information, coupled with an increasing business focus on data analytics is making it easier for companies to generate meaningful sales opportunities, according to a recent study. Growing the life science industry's data generation and turning it into valuable data are major factors that create a lot of sales opportunities worldwide.
Key Challenges Influencing Life Science Analytics Market Expansion
There is a greater risk of leaking sensitive patient information to unauthorized individuals as a result of the growing number of databases shared between research institutions, clinical research organizations, and software companies. As patient databases are increasingly being maintained electronically, concerns over data security and privacy are rising. Compliance with privacy policies and the use of analytics solutions pose a critical challenge for pharmaceutical enterprises.
As a result of high costs, small- and medium-sized biotech companies, pharmaceutical companies, and contract research organizations (CROs) with limited resources have a hard time affording these solutions. As a result of this trend, emerging economies in particular are struggling to secure budgets for medical equipment over IT.
A major challenge when it comes to streamlining analytics is the availability of vast amounts of data from various sources, ranging in various formats and quality levels, which can make it difficult to streamline them.
Research and Development and regulatory shifts are posing challenges to the life science and pharmaceutical industries. Under the Affordable Care Act (ACA), the regulatory framework in the USA is evolving, requiring an increased level of scrutiny and reimbursement based on health outcomes. In the USA, most companies implement analytics internally or utilize third-party services to assist with these challenges.
Find your sweet spots for generating winning opportunities in this market.
Comparative View of Life Science Analytics Market
Life Science Analytics Market:
Attributes
Life Science Analytics Market
CAGR (2022 to 2032)
10.7%
Market Value (2026)
US$ 39.9 Billion
Growth Factor
Advancements in technology, a large amount of data in the life sciences industry, increasing adoption of analytics solutions in clinical trials, and adoption of analytics for marketing and sales applications.
Opportunity
Utilizing computer models and predictive analytics are important tools to help healthcare organizations provide individualized care to their patients.
Key Trends
Companies in the pharmaceutical and biotech industries are developing medicines and vaccines for covid-19 and are conducting clinical trials for the disease. This will further provide growth opportunities in the market.
Software Life Science Analytics Market:
Attributes
Software Life Science Analytics Market
CAGR (2022 to 2032)
10.1%
Market Value (2026)
US$ 23.1 Billion
Growth Factor
Developing safe therapies to cure patients is one of the largest key factors driving the growth in the market.
Opportunity
Growth in digital health and improving the way to develop, manufacture, and commercialize effective treatments to gain a foothold in the market.
Key Trends
As AI-centric life science analytics software continues to evolve, the technology and trends relating to it are expected to generate massive demands, resulting in market growth.
Research and Development Life Science Analytics Market:
Attributes
Research and Development Life Science Analytics Market
CAGR (2022 to 2032)
11.8%
Market Value (2026)
US$ 11.7 Billion
Growth Factor
The growing demand to develop new, trusted, and customized medicines and therapies that don't compromise quality or safety is only expected to increase in the future.
Opportunity
By enhancing the search and analysis efficiency of complex chemical space, and enhancing trial management, recruitment, and patient reporting, researchers can increase the efficiency of clinical trials. With AI, analytics, and data science, scientists can explore the relationships, behaviors, and genetic factors that drive disease.
Key Trends
Health expenditure is expected to rise as a result of improving patient outcomes, and government funding for healthcare research is expected to rise. An emerging market for advanced analytics solutions is also expected to drive future growth.
The market for life science analytics is anticipated to further grow due to the increasing demand for improved data standardization. As startups emerge, technology collaborations are growing, and funding opportunities are favorable, helping services grow. The market for life science analytics is expected to gain further ground as chronic diseases become more prevalent. In contrast, the growth of life science analytics could be hindered by increasing application costs over the timeline.
It's expected that biotech companies will grow the fastest in the coming years. The proliferation of genome sequencing and analysis solutions has facilitated this growth rate for biotech companies. The adoption of advanced analytical solutions by organizations and other stakeholders continues to rise as healthcare digitization progresses. Utilizing these advanced analytics solutions enabled key players to efficiently manage medical resources and supply chains, engage with customers, and provide workforce management solutions.
As healthcare becomes more digital and healthcare IT infrastructure advances, analytical solutions, and medical services are in growing demand. As digital literacy increases and government initiatives gain traction, analytical solutions are becoming more in demand. Demand for services is driven by the increasing integration of artificial intelligence algorithms with analytical tools and the adoption of big data analytics. Additionally, the use of customized analytics is helping drive the segment's growth and development in the market. Due to the increasing adoption rate of web-based and cloud-based analytical applications and solutions, as well as advances in internet connectivity, these solutions are becoming more accessible from remote regions in the market.
What Role do Software Components Play in the Growth of the Life Science Analytics Market?
As pharmaceutical companies have begun applying enhanced analytical tools to increase the efficacy of their products to treat diseases with grave effects, the global market for life science analytics software is expected to grow at an exponential rate.
Due to an increase in the use of life science analytics software to study the efficacy of COVID-19 and develop a drug to treat those infected, the outbreak of COVID-19 has had a positive impact on the global life science analytics market.
With major technological innovations taking place across the healthcare and information technology sectors, the market for life science analytics software will experience a significant boost. This is due to increased access from remote locations, along with minimal costs and maintenance requirements. According to Future Market Insights, life science analytics software will experience a value CAGR worth 10.1% from 2022 to 2032.
In addition, there is a high likelihood that the on-demand delivery segment will experience the most rapid growth rates during the forecast period. As a result of its reliability and accuracy, artificial intelligence is used extensively around the world.
AI offers a very effective way to reduce healthcare costs and the ease with which drug development processes can be carried out. Based on the factors mentioned above, the global life science analytics software market is expected to expand considerably in the years to come.
With on-demand analytics, applications saved, and data retrieved according to user requirements, organizations can reduce infrastructure space and allow users to consume resources based on their needs. Storage capacity, ease of access, and enhanced security are some of the benefits of on-demand analytical solutions.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
What role does Research and Development play in accelerating the growth of the Life Science Analytics Market?
Pharma companies are able to identify potential drugs with a high probability of succeeding in the Research and Development process and clinical research by mining vast amounts of data generated during these processes. In general, contract research organizations (CROs) provide real-time analysis and create alerts for each department concerning the safety or efficacy of drugs or clinical studies, through established systems for data capture and analytical tools. Research and Development applications are expected to grow at a CAGR of 11.8% during the forecast period.
The use of analytics may be able to reduce the time and expenses associated with the development of a potential drug candidate. The use of analytics is becoming more common among pharmaceutical companies.
One such solution was developed by Eli Lilly, which provides researchers with an easy way to conduct a screening without compromising the integrity of the intellectual property they hold. As investments increase from various organizations in life sciences for drug discovery and development, the market demand for Research and Development applications will continue to grow in the future.
A rise in the adoption of analytical solutions for drug discovery and development and clinical trial management is expected to drive growth in the research and development segment over the forecast period. The growth of life science organizations is another factor positively affecting the growth in the research and development sector.
It is expected that the market demand for developing vaccines for Covid-2019 will increase, thereby further helping to boost Research and Development activities in the market. Oracle and Cognizant, for instance, entered into a technology partnership in January 2021 to create solutions that would speed up clinical trials based on a combination of Oracle's Health Science solution and Cognizant's Shared Investigator Platform.
Life Science Analytics Regional Outlook
How do the Various Regions Influence the Growth of the Life Science Analytics Market?
Ongoing Investments to Beef up Healthcare to Drive APAC Market Growth
Asia Pacific is expected to grow at the fastest rate during the forecast period. A growing number of chronic diseases and the growth of the life science industry, along with the adoption of new technology, drive growth in Asia over the forecast period. An array of factors contributes to increases in healthcare IT expenditures, including improvements in the infrastructure, emerging industry players, and an increase in the level of digital literacy within the population.
The market is expected to be driven by economic growth and the availability of low-cost and highly skilled-workers. As part of their plans to expand their operations in the Asia Pacific, major players are devising strategies to enter the market. India is forecast to exhibit a 12.7% growth rate, followed by China with a 12.5% growth rate.
An increase in investment in emergency care, coupled with the growth of automation in the pharmaceutical industry, and the use of technologies such as predictive analytics, big data, and strategic partnerships have resulted in the adoption of global life science analytics during the forecast period.
The market value of life science analytics in Japan is expected to reach value of US$ 3.2 Billion during the forecast period. It is expected that the market will grow at a CAGR of 12.3% during the forecast period.
Several factors, such as the rise in disposable income, the increasing incidence of injuries, and the improvement in healthcare infrastructure across this region will boost the global life science analytics market. Data privacy concerns and high implementation costs may further hamper the market's growth during the forecast period.
What are the Growth Prospects of the Life Science Analytics Market in the USA and UK?
The US life science analytics market is anticipated to surge at a CAGR of 10.7% until 2032, driven by the increase in the most COVID-affected country across the world. The development of therapeutics for this disease is a priority for pharmaceutical companies, and several trials are being conducted in the USA.
For new drug discovery or drug development companies, analytics is important for tracking those trails and managing the data they generate. In the USA, the Affordable Care Act (ACA) has transformed the regulatory framework, increased the level of scrutiny, and increased reimbursements based on results. Rather than employing third-party services, most American companies implement their own analytics practices.
A compound annual growth rate of 9.9% will be experienced by the life science analytics market in the UK during the forecast period. Throughout the foreseeable future, the market is expected to gain traction due to the prevalent use of big data and artificial intelligence in healthcare.
As social media continues to impose a growing impact on the healthcare sector, the market is experiencing rapid growth in the market. The growing demand for pharmaceutical exports from these regions will further increase the market demand for the life science analytics market.
How Competitive is the Life Science Analytics Market?
In addition to increasing revenue and market share, strategic partnerships allow manufacturers to meet consumer demand and increase production. Through the introduction of new products and technologies, end users will reap the benefits of new technologies. As a result of a strategic partnership, the company can increase its production capacity.
Life Science Analytics Market Developments
In September 2021, SENSIGHT built an extensive set of anonymized and de-identified patient data collected through Sensyne's research relationships with NHS Trusts and USA Health Systems, which cover 22.5 million patients across a wide range of diseases. In addition, the data analytics platform also includes integrated, easy-to-use research algorithms. In the coming years, the platform will add researchable disease areas, analytical tools, and patient data as it moves toward its goal of containing 100 million patient records by 2024.
Donaldson Co Inc. acquired Solaris Biotechnology Srl, a leading manufacturer and designer of bioprocessing equipment, including bioreactors, fermenters, and tangential flow filtration systems, for €41 million in November 2021. Solaris has impressive capabilities and a growth trajectory, which makes this acquisition a significant step in our strategy to strengthen its presence in the life sciences sector.
By April 2022, Bayer AG plans to invest over 1.3 billion euros in Leaps by Bayer, its impact investment unit. A primary focus of the company will be to develop solutions for patients in areas of high unmet medical need with the help of leading pharmaceutical technology platforms like Cell & Gene Therapy. In order to ensure food security and decarbonize agriculture, agritech company will present its innovations.
Key Players
Accenture Plc.
Cognizant Technology Solutions Corporation
IBM Corporation
MaxisIT, Inc.
Oracle Corporation
IQVIA (Quintiles, Inc.)
SAS Institute Inc.
Scio Health Analytics
Take Solutions, Inc.
Wipro Limited
SAP SE
Key Segments Covered in the Life Science Analytics Industry Report
By Component:
Software
On-premise
On-demand
Services
Professional
Managed
By Application:
Clinical and Preclinical Trials
Regulatory Compliance
Research and Development
Sales and Marketing
Supply Chain Management
By Type:
Descriptive
Predictive
Prescriptive
By End-Use Application:
Biomedical Companies
Laboratory and Pharmaceuticals
Medical Device Companies
By Region:
North America
Europe
Asia Pacific
Middle East and Africa
South America
Frequently Asked Questions
What is the growth outlook for the life science analytics market?
The life science analytics market is expected to grow at a steady CAGR of 10.7% over the forecast period.
What was the size of the life science analytics market size in 2021?
The global market for life science analytics was valued at US$ 22.1 Billion in 2021
Which application has the highest market value in the life science analytics market?
Life science analytics for research & development is expected to showcase a CAGR of 11.8% during the forecast period
Which country dominates the global life science analytics market?
India is expected to be the main hub for life science analytics, experiencing a CAGR of 12.7%
What will be the market size of life science analytics by 2032?
The market for life science analytics is expected to grow by nearly US$ 68.6 Billion by 2032
What is the projected dollar growth of life science analytics from 2022 to 2032?
The absolute dollar growth of life science analytics is estimated at US$ 43.9 Billion
Table of Content
1. Preface | Life Science Analytics Market
1.1. Market Scope
1.2. Market Segmentation
1.3. Key Research Objectives
2. Assumptions and Research Methodology
2.1. Market Taxonomy - Segment Definitions
2.2. Research Methodology
2.2.1. List of Primary and Secondary Sources
2.3. Key Assumptions for Data Modeling
3. Executive Summary: Global Market4. Market Overview
4.1. Introduction
4.2. Global Market - Macro Economic Factors Overview
4.2.1. World GDP Indicator - For Top 20 Economies
4.2.2. Global ICT Spending (US$ Million), 2016 to 2032
4.3. Technology/Product Roadmap
4.4. Market Factor Analysis
4.4.1. Porter’s Five Forces Analysis
4.4.2. PESTLE Analysis
4.4.3. Ecosystem Analysis
4.5. Market Dynamics (Growth Influencers)
4.5.1. Drivers
4.5.2. Restraints
4.5.3. Opportunities
4.5.4. Key Trends
4.6. Regulations and Policies
4.7. Impact of Big Data Analytics on the Life Science Industry
4.8. Pricing Model
4.8.1. Subscription
4.8.2. License
4.9. Global Market Analysis and Forecast, 2016 to 2032
4.9.1. Market Revenue Analysis (US$ Million)
4.9.1.1. Historic growth trends, 2016 to 2021
4.9.1.2. Forecast trends, 2016 to 2032
4.10. Market Opportunity Analysis - (By Region/Country (Global/North America/Europe/Asia Pacific/Middle East & Africa/South America)
4.10.1. By Region/Country
4.10.2. By Component
4.10.3. By Type
4.10.4. By Application
4.10.5. By End-user
4.11. Competitive Scenario and Trends
4.11.1. Market Concentration Rate
4.11.1.1. List of New Entrants
4.11.2. Mergers & Acquisitions, Expansions
4.12. Market Outlook
5. Global Market Analysis and Forecast, By Component
5.1. Overview and Definition
5.2. Market Size (US$ Million) Forecast, By Component, 2016 to 2032
5.2.1. Software
5.2.1.1. On-premise
5.2.1.2. On-demand
5.2.2. Service
5.2.2.1. Professional
5.2.2.2. Managed
6. Global Market Analysis and Forecast, By Type
6.1. Overview and Definition
6.2. Market Size (US$ Million) Forecast, By Type, 2016 to 2032
6.2.1. Descriptive Analytics
6.2.2. Predictive Analytics
6.2.3. Prescriptive Analytics
7. Global Market Analysis and Forecast, By Application
7.1. Overview and Definition
7.2. Market Size (US$ Million) Forecast, By Application, 2016 to 2032
7.2.1. Clinical and Preclinical Trials
7.2.2. Regulatory Compliance
7.2.3. Research and Development
7.2.4. Sales and Marketing
7.2.5. Supply Chain Management
8. Global Market Analysis and Forecast, By End-user
8.1. Overview
8.2. Market Size (US$ Million) Forecast, By End-user, 2016 to 2032
8.2.1. Medical Device Companies
8.2.2. Laboratory and Pharmaceutical Companies
8.2.3. Biomedical Companies
9. Global Market Analysis and Forecast, by Region
9.1. Overview
9.2. Market Size (US$ Million) Forecast, by Region, 2016 to 2032
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Middle East and Africa
9.2.5. South America
10. North America Market Analysis and Forecast
10.1. Key Findings
10.2. Market Size (US$ Million) Forecast, By Component, 2016 to 2032
10.2.1. Software
10.2.1.1. On-premise
10.2.1.2. On-demand
10.2.2. Service
10.2.2.1. Professional
10.2.2.2. Managed
10.3. Market Size (US$ Million) Forecast, By Type, 2016 to 2032
10.3.1. Descriptive Analytics
10.3.2. Predictive Analytics
10.3.3. Prescriptive Analytics
10.4. Market Size (US$ Million) Forecast, By Application, 2016 to 2032
10.4.1. Clinical and Preclinical Trials
10.4.2. Regulatory Compliance
10.4.3. Research and Development
10.4.4. Sales and Marketing
10.4.5. Supply Chain Management
10.5. Market Size (US$ Million) Forecast, By End-user, 2016 to 2032
10.5.1. Medical Device Companies
10.5.2. Laboratory and Pharmaceutical Companies
10.5.3. Biomedical Companies
10.6. Market Size (US$ Million) Forecast, By Country, 2016 to 2032
10.6.1. The USA
10.6.2. Canada
10.6.3. Rest of North America
11. Europe Market Analysis and Forecast
11.1. Key Findings
11.2. Market Size (US$ Million) Forecast, By Component, 2016 to 2032
11.2.1. Software
11.2.1.1. On-premise
11.2.1.2. On-demand
11.2.2. Service
11.2.2.1. Professional
11.2.2.2. Managed
11.3. Market Size (US$ Million) Forecast, By Type, 2016 to 2032
11.3.1. Descriptive Analytics
11.3.2. Predictive Analytics
11.3.3. Prescriptive Analytics
11.4. Market Size (US$ Million) Forecast, By Application, 2016 to 2032
11.4.1. Clinical and Preclinical Trials
11.4.2. Regulatory Compliance
11.4.3. Research and Development
11.4.4. Sales and Marketing
11.4.5. Supply Chain Management
11.5. Market Size (US$ Million) Forecast, By End-user, 2016 to 2032
11.5.1. Medical Device Companies
11.5.2. Laboratory and Pharmaceutical Companies
11.5.3. Biomedical Companies
11.6. Market Size (US$ Million) Forecast, By Country, 2016 to 2032
11.6.1. Germany
11.6.2. UK
11.6.3. France
11.6.4. Rest of Europe
12. Asia Pacific Market Analysis and Forecast
12.1. Key Findings
12.2. Market Size (US$ Million) Forecast, By Component, 2016 to 2032
12.2.1. Software
12.2.1.1. On-premise
12.2.1.2. On-demand
12.2.2. Service
12.2.2.1. Professional
12.2.2.2. Managed
12.3. Market Size (US$ Million) Forecast, By Type, 2016 to 2032
12.3.1. Descriptive Analytics
12.3.2. Predictive Analytics
12.3.3. Prescriptive Analytics
12.4. Market Size (US$ Million) Forecast, By Application, 2016 to 2032
12.4.1. Clinical and Preclinical Trials
12.4.2. Regulatory Compliance
12.4.3. Research and Development
12.4.4. Sales and Marketing
12.4.5. Supply Chain Management
12.5. Market Size (US$ Million) Forecast, By End-user, 2016 to 2032
12.5.1. Medical Device Companies
12.5.2. Laboratory and Pharmaceutical Companies
12.5.3. Biomedical Companies
12.6. Market Size (US$ Million) Forecast, By Country, 2016 to 2032
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia
12.6.5. Rest of Asia Pacific
13. Middle East and Africa (MEA) Market Analysis and Forecast
13.1. Key Findings
13.2. Market Size (US$ Million) Forecast, By Component, 2016 to 2032
13.2.1. Software
13.2.1.1. On-premise
13.2.1.2. On-demand
13.2.2. Service
13.2.2.1. Professional
13.2.2.2. Managed
13.3. Market Size (US$ Million) Forecast, By Type, 2016 to 2032
13.3.1. Descriptive Analytics
13.3.2. Predictive Analytics
13.3.3. Prescriptive Analytics
13.4. Market Size (US$ Million) Forecast, By Application, 2016 to 2032
13.4.1. Clinical and Preclinical Trials
13.4.2. Regulatory Compliance
13.4.3. Research and Development
13.4.4. Sales and Marketing
13.4.5. Supply Chain Management
13.5. Market Size (US$ Million) Forecast, By End-user, 2016 to 2032
13.5.1. Medical Device Companies
13.5.2. Laboratory and Pharmaceutical Companies
13.5.3. Biomedical Companies
13.6. Market Size (US$ Million) Forecast, By Country, 2016 to 2032
13.6.1. GCC Countries
13.6.2. South Africa
13.6.3. Rest of MEA
14. South America Market Analysis and Forecast
14.1. Key Findings
14.2. Market Size (US$ Million) Forecast, By Component, 2016 to 2032
14.2.1. Software
14.2.1.1. On-premise
14.2.1.2. On-demand
14.2.2. Service
14.2.2.1. Professional
14.2.2.2. Managed
14.3. Market Size (US$ Million) Forecast, By Type, 2016 to 2032
14.3.1. Descriptive Analytics
14.3.2. Predictive Analytics
14.3.3. Prescriptive Analytics
14.4. Market Size (US$ Million) Forecast, By Application, 2016 to 2032
14.4.1. Clinical and Preclinical Trials
14.4.2. Regulatory Compliance
14.4.3. Research and Development
14.4.4. Sales and Marketing
14.4.5. Supply Chain Management
14.5. Market Size (US$ Million) Forecast, By End-user, 2016 to 2032
14.5.1. Medical Device Companies
14.5.2. Laboratory and Pharmaceutical Companies
14.5.3. Biomedical Companies
14.6. Market Size (US$ Million) Forecast, By Country, 2016 to 2032
14.6.1. Brazil
14.6.2. Rest of South America
15. Competition Landscape
15.1. Market Player - Competition Matrix
15.2. Market Revenue Share Analysis (%), by Company (2021)
16. Company Profiles
16.1. Accenture PLC
16.1.1. Company Overview
16.1.2. Product Overview
16.1.3. Financial Overview
16.1.4. Strategic Overview
16.2. Cognizant Technology Solutions Corporation
16.2.1. Company Overview
16.2.2. Product Overview
16.2.3. Financial Overview
16.2.4. Strategic Overview
16.3. IBM Corporation
16.3.1. Company Overview
16.3.2. Product Overview
16.3.3. Financial Overview
16.3.4. Strategic Overview
16.4. MaxisIT, Inc.
16.4.1. Company Overview
16.4.2. Product Overview
16.4.3. Financial Overview
16.4.4. Strategic Overview
16.5. Oracle Corporation
16.5.1. Company Overview
16.5.2. Product Overview
16.5.3. Financial Overview
16.5.4. Strategic Overview
16.6. IQVIA (Quintiles, Inc.)
16.6.1. Company Overview
16.6.2. Product Overview
16.6.3. Financial Overview
16.6.4. Strategic Overview
16.7. SAS Institute Inc.
16.7.1. Company Overview
16.7.2. Product Overview
16.7.3. Financial Overview
16.7.4. Strategic Overview
16.8. Scio Health Analytics
16.8.1. Company Overview
16.8.2. Product Overview
16.8.3. Financial Overview
16.8.4. Strategic Overview
16.9. Take Solutions, Inc.
16.9.1. Company Overview
16.9.2. Product Overview
16.9.3. Financial Overview
16.9.4. Strategic Overview
16.10. Wipro Limited
16.10.1. Company Overview
16.10.2. Product Overview
16.10.3. Financial Overview
16.10.4. Strategic Overview
16.11. SAP SE
16.11.1. Company Overview
16.11.2. Product Overview
16.11.3. Financial Overview
16.11.4. Strategic Overview
17. Key Takeaways
List of Tables
Table 1: Global Market Size (US$ Million) Forecast, by Component, 2016 to 2032
Table 2: Global Market Size (US$ Million) Forecast, by Software, 2016 to 2032
Table 3: Global Market Size (US$ Million) Forecast, by Services, 2016 to 2032
Table 4: Global Market Size (US$ Million) Forecast, by Type, 2016 to 2032
Table 5: Global Market Size (US$ Million) Forecast, by Application, 2016 to 2032
Table 6: Global Market Size (US$ Million) Forecast, by End-user, 2016 to 2032
Table 7: Global Market Size (US$ Million) Forecast, by Region, 2016 to 2032
Table 8: North America Market Size (US$ Million) Forecast, by Component,2016 to 2032
Table 9: North America Market Size (US$ Million) Forecast, by Software, 2016 to 2032
Table 10: North America Market Size (US$ Million) Forecast, by Services, 2016 to 2032
Table 11: North America Market Size (US$ Million) Forecast, by Type, 2016 to 2032
Table 12: North America Market Size (US$ Million) Forecast, by Application, 2016 to 2032
Table 13: North America Market Size (US$ Million) Forecast, by End-user, 2016 to 2032
Table 14: North America Market Size (US$ Million) Forecast, by Country, 2016 to 2032
Table 15: Europe Market Size (US$ Million) Forecast, by Component, 2016 to 2032
Table 16: Europe Market Size (US$ Million) Forecast, by Software, 2016 to 2032
Table 17: Europe Market Size (US$ Million) Forecast, by Services, 2016 to 2032
Table 18: Europe Market Size (US$ Million) Forecast, by Type, 2016 to 2032
Table 19: Europe Market Size (US$ Million) Forecast, by Application, 2016 to 2032
Table 20: Europe Market Size (US$ Million) Forecast, by End-user, 2016 to 2032
Table 21: Europe Market Size (US$ Million) Forecast, by Country, 2016 to 2032
Table 22: Asia Pacific Market Size (US$ Million) Forecast, by Component, 2016 to 2032
Table 23: Asia Pacific Market Size (US$ Million) Forecast, by Software, 2016 to 2032
Table 24: Asia Pacific Market Size (US$ Million) Forecast, by Services, 2016 to 2032
Table 25: Asia Pacific Market Size (US$ Million) Forecast, by Type, 2016 to 2032
Table 26: Asia Pacific Market Size (US$ Million) Forecast, by Application, 2016 to 2032
Table 27: Asia Pacific Market Size (US$ Million) Forecast, by End-user, 2016 to 2032
Table 28: Asia Pacific Market Size (US$ Million) Forecast, by Country, 2016 to 2032
Table 29: Middle East & Africa Market Size (US$ Million) Forecast, by Component, 2016 to 2032
Table 30: Middle East & Africa Market Size (US$ Million) Forecast, by Software, 2016 to 2032
Table 31: Middle East & Africa Market Size (US$ Million) Forecast, by Services, 2016 to 2032
Table 32: Middle East & Africa Market Size (US$ Million) Forecast, by Type, 16 to 2032
Table 33: Middle East & Africa Market Size (US$ Million) Forecast, by Application, 2016 to 2032
Table 34: Middle East & Africa Market Size (US$ Million) Forecast, by End-user, 2016 to 2032
Table 35: Middle East & Africa Market Size (US$ Million) Forecast, by Country, 2016 to 2032
Table 36: South America Market Size (US$ Million) Forecast, by Component, 2016 to 2032
Table 37: South America Market Size (US$ Million) Forecast, by Software, 2016 to 2032
Table 38: South America Market Size (US$ Million) Forecast, by Services, 2016 to 2032
Table 39: South America Market Size (US$ Million) Forecast, by Type, 2016 to 2032
Table 40: South America Market Size (US$ Million) Forecast, by Application, 2016 to 2032
Table 41: South America Market Size (US$ Million) Forecast, by End-user, 2016 to 2032
Table 42: South America Market Size (US$ Million) Forecast, by Country, 2016 to 2032
List of Charts
Figure 1: Research Methodology
Figure 2: Global Market Size (US$ Million) Forecast, 2016 to 2032
Figure 3: Global Market Value (US$) Opportunity Assessment, by Region, 2021E
Figure 4: Global Market Value (US$) Opportunity Assessment, by Region, 2021F
Figure 5: World GDP Indicator (2021)
Figure 6: Global ICT Spending (US$ Billion)
Figure 7: Data Sources and Data Flow In Life Science Industry
Figure 8: Global Market Size (US$ Million) and Forecast, 2016 to 2032
Figure 9: Global Market Opportunity Analysis, 2016 to 2032
Figure 10: Global Market Attractiveness Analysis, by Component
Figure 11: Global Market Attractiveness Analysis, by Application
Figure 12: Global Market Attractiveness Analysis, by Type
Figure 13: Global Market Attractiveness Analysis, by End-user
Figure 14: Global Market Attractiveness Analysis, by Region
Figure 15: North America Market Attractiveness Analysis, by Component
Figure 16: North America Market Attractiveness Analysis, by Application
Figure 17: North America Market Attractiveness Analysis, by Type
Figure 18: North America Market Attractiveness Analysis, by End-user
Figure 19: North America Market Attractiveness Analysis, by Country
Figure 20: Europe Market Attractiveness Analysis, by Component
Figure 21: Europe Market Attractiveness Analysis, by Application
Figure 22: Europe Market Attractiveness Analysis, by Type
Figure 23: Europe Market Attractiveness Analysis, by End-user
Figure 24: Europe Market Attractiveness Analysis, by Country
Figure 25: Asia Pacific Market Attractiveness Analysis, by Component
Figure 26: Asia Pacific Market Attractiveness Analysis, by Application
Figure 27: Asia Pacific Market Attractiveness Analysis, by Type
Figure 28: Asia Pacific Market Attractiveness Analysis, by End-user
Figure 29: Asia Pacific Market Attractiveness Analysis, by Country
Figure 30: Middle East & Africa Market Attractiveness Analysis, by Component
Figure 31: Middle East & Africa Market Attractiveness Analysis, by Application
Figure 32: Middle East & Africa Market Attractiveness Analysis, by Type
Figure 33: Middle East & Africa Market Attractiveness Analysis, by End-user
Figure 34: Middle East & Africa Market Attractiveness Analysis, by Country
Figure 35: South America Market Attractiveness Analysis, by Component
Figure 36: South America Market Attractiveness Analysis, by Application
Figure 37: South America Market Attractiveness Analysis, by Type
Figure 38: South America Market Attractiveness Analysis, by End-user
Figure 39: South America Market Attractiveness Analysis, by Country
Figure 40: Global Market Revenue (US$ Million) and Y-o-Y Forecast, 2016 to 2032
Figure 41: Global Opportunity Growth Analysis (US$ Million) Forecast, 2016 to 2032
Figure 42: Global Market Value Share (Value %), by Component, 2021
Figure 43: Global Market Value Share (Value %), by Type, 2021
Figure 44: Global Oil and Gas Data Indirect Monetization Market Value Share (Value %), by End-user, 2021
Figure 45: Global Market Value Share (Value ), by Application, 2021
Figure 46: Global Market Value Share (Value %), by Component, 2021
Figure 47: Global Market Value Share (Value %), by Type, 2021
Figure 48: Global Oil and Gas Data Indirect Monetization Market Value Share (Value %), by End-user, 2021
Figure 49: Global Market Value Share (Value %), by Application, 2021
Figure 50: North America Market Revenue (US$ Million) and Y-o-Y Forecast, 2016 to 2032
Figure 51: North America Opportunity Growth Analysis (US$ Million) Forecast, 2016 to 2032
Figure 52: Europe Market Revenue (US$ Million) and Y-o-Y Forecast, 2016 to 2032
Figure 53: Europe Opportunity Growth Analysis (US$ Million) Forecast, 2016 to 2032
Figure 54: Asia Pacific Market Revenue (US$ Million) and Y-o-Y Forecast, 2016 to 2032
Figure 55: Asia Pacific Opportunity Growth Analysis (US$ Million) Forecast, 2016 to 2032
Figure 56: Middle East and Africa Market Revenue (US$ Million) and Y-o-Y Forecast,2016 to 2032
Figure 57: Middle East and Africa Opportunity Growth Analysis (US$ Million) Forecast,2016 to 2032
Figure 58: South America Market Revenue (US$ Million) and Y-o-Y Forecast, 2016 to 2032
Figure 59: South America Opportunity Growth Analysis (US$ Million) Forecast, 2016 to 2032
Figure 60: Life Science Analytics Market Share Assessment (%), by Company (2021)
